Table 1 Clinical characteristics of 127 HIV-infected patients with non-AIDS defining cancer (NADC)
Characteristics—N (%) | Total | Women (n = 26, 20.5) | Men (n = 101, 79.5) |
|---|---|---|---|
Age (years)a | 43.7 ± 10.9 | 49 ± 11.1 | 42.3 ± 10.5 |
BMI | 23.9 ± 4 | 24.6 ± 3.9 | 23.7 ± 4 |
Smoking | 67 (52.7) | 9 (34.6) | 58 (57.4) |
Alcohol consumption | 68 (53.5) | 6 (23) | 62 (61.4) |
HIV transmission mode | |||
MSM | 65 (51.2) | 0 | 65 (64.3) |
Heterosexual | 55 (43.3) | 22 (84.6) | 34 (33.7) |
Transfusion | 2 (1.6) | 1 (3.8) | 1 (1) |
Unknown | 4 (3.1) | 3 (11.5) | 1 (1) |
cART at NADC diagnosis | 93 (73.2) | 21 (80.7) | 74 (73.3) |
NRTI + NNRTI | 54 (58) | 6 (2.9) | 48 (64.9) |
NRTI plus PI/r | 29 (31.2) | 9 (4.3) | 20 (27) |
NRTI + NNRTI + PI/r | 5 (5.4) | 3 (1.4) | 2 (2.7) |
Other | 7 (7.5) | 3 (1.4) | 4 (5.4) |
CD4 (cells/µL) at nadirbc | 132 (47, 278) | 106 (12, 249) | 145 (50, 284) |
< 200 | 40 (61.9) | 6 (66.7) | 34 (61.8) |
> 200 | 24 (38.1) | 3 (33.3) | 21 (38.2) |
Viral load at HIV diagnosis (copies/mL)cd | 98,922 (37,053; 413,856) | 307,395 (26,676; 875,000) | 98,922 (37,495; 242,356) |
CD4 at NADC diagnosisde | 273 (125; 481) | 477 (300; 805) | 231 (114; 380) |
< 200 | 44 (38.5) | 5 (20) | 39 (43.8) |
> 200 | 70 (61.4) | 20 (80) | 50 (57.3) |
Undetectable viral load at NADC diagnosisf | 73 (65.7) | 21 (84) | 52 (60.4) |
Viral load at NADC diagnosiscg | 37,053 (4950; 107,064) | 30,915 (145; 37,053) | 39,951 (8751; 109,072) |